New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
06:08 EDTADHDBioBlast said to be preparing $37.5M Nasdaq IPO, Globes reports
BioBlast Pharma, an Israeli drug development company, is preparing a $37.5M Nasdaq IPO, sources tell Globes. BioBlast founders Dr. Dalia Megiddo and Udi Gilboa took Alcobra Pharmaceuticals public in 2013, raising $25M last May and another $38M in a secondary offering in October. Reference Link
News For ADHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ADHD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use